Newsroom Search

featured news

May 30, 2013 General

New Guidelines Explain How State False Claims Acts Will be Evaluated

For the first time, the guidelines for evaluating state false claims acts have been updated. The Office of the Inspector General for Health and Human Services (OIG) recently released an updated set of state False Claims Acts guidelines, providing details as to how the laws will now be evaluated by […]
May 29, 2013 General

Jury Finds State Farm Guilty in False Claims Act Lawsuit

After a lengthy legal battle, a panel of 12 jury members in Mississippi federal court found State Farm Fire and Casualty Co. (State Farm) guilty of violating the False Claims Act. State Farm, the country’s largest insurer of homes, faced allegations that it defrauded the National Flood Insurance Program (NFIP) […]
May 28, 2013 General

The United States Government Intervenes in False Claims Act Lawsuit Against Agave BioSystems

Taking another step toward ending the widespread problem of defense contractor fraud, the United States government has joined a False Claims Act lawsuit against a New York-based biotech company. Agave BioSystems, founded in 1998, is accused of fraudulently billing the United States Department of Defense (DOD) for an estimated $15 […]
May 27, 2013 General

U.S. Renal Care Settles False Claims Act Lawsuit for $7.3 Million

A Texas-based dialysis clinic recently agreed to a $7.3 million settlement with the United States government, resolving allegations of Medicare fraud contained in a False Claims Act lawsuit. U.S. Renal Care, who acquired Dialysis Corporation of America (DCA) in June 2010, is accused of knowingly overbilling Medicare for Epogen, a […]
May 24, 2013 General

Boehringer Ingelheim Pharmaceuticals Settles Whistleblower Lawsuit for $95 Million

Thanks to the extraordinary efforts of one whistleblower, along with a thorough investigation conducted by the Health Care Fraud Prevention and Enforcement Action Team (“HEAT”), another pharmaceutical manufacturer agreed to settle a False Claims Act lawsuit.  According to the United States Department of Justice (“DOJ”), Boehringer Ingelheim Pharmaceuticals Inc. will […]